Fat attenuation index (FAI): a paradigm shift in cardiology.
Medscape Brazil have featured Dr Cheerag Shirodaria for his work within the industry.
Cheerag Shirodaria is a Cardiologist and Honorary Adviser to the Oxford University Hospitals NHS Foundation Trust in the United Kingdom. He is also co-founder and CEO of Caristo Diagnostics , a University of Oxford spinout company . Cheerag and team developed the Fat Attenuation Index (FAI ) , a non-invasive method to measure alterations that lead to atherosclerosis from the analysis of coronary CT angiography. In an interview with Medscape , Dr. Cheerag shared more details about the FAI.
You can read the full article on Medscape.
Read more
April 2024
Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers
Caristo’s AI technology predicts heart attack risk for employee wellness initiative from respected centre of excellence OXFORD, England and SURREY, England , April 23,…
Read more
April 2024
American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab
Caristo’s CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50%…